Literature DB >> 10441342

Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome.

M Kalff-Suske1, A Wild, J Topp, M Wessling, E M Jacobsen, D Bornholdt, H Engel, H Heuer, C M Aalfs, M G Ausems, R Barone, A Herzog, P Heutink, T Homfray, G Gillessen-Kaesbach, R König, J Kunze, P Meinecke, D Müller, R Rizzo, S Strenge, A Superti-Furga, K H Grzeschik.   

Abstract

Greig cephalopolysyndactyly syndrome, characterized by craniofacial and limb anomalies (GCPS; MIM 175700), previously has been demonstrated to be associated with translocations as well as point mutations affecting one allele of the zinc finger gene GLI3. In addition to GCPS, Pallister-Hall syndrome (PHS; MIM 146510) and post-axial polydactyly type A (PAP-A; MIM 174200), two other disorders of human development, are caused by GLI3 mutations. In order to gain more insight into the mutational spectrum associated with a single phenotype, we report here the extension of the GLI3 mutation analysis to 24 new GCPS cases. We report the identification of 15 novel mutations present in one of the patient's GLI3 alleles. The mutations map throughout the coding gene regions. The majority are truncating mutations (nine of 15) that engender prematurely terminated protein products mostly but not exclusively N-terminally to or within the central region encoding the DNA-binding domain. Two missense and two splicing mutations mapping within the zinc finger motifs presumably also interfere with DNA binding. The five mutations identified within the protein regions C-terminal to the zinc fingers putatively affect additional functional properties of GLI3. In cell transfection experiments using fusions of the DNA-binding domain of yeast GAL4 to different segments of GLI3, transactivating capacity was assigned to two adjacent independent domains (TA(1)and TA(2)) in the C-terminal third of GLI3. Since these are the only functional domains affected by three C-terminally truncating mutations, we postulate that GCPS may be due either to haploinsufficiency resulting from the complete loss of one gene copy or to functional haploinsufficiency related to compromised properties of this transcription factor such as DNA binding and transactivation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441342     DOI: 10.1093/hmg/8.9.1769

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

Review 1.  The sonic hedgehog-patched-gli pathway in human development and disease.

Authors:  E H Villavicencio; D O Walterhouse; P M Iannaccone
Journal:  Am J Hum Genet       Date:  2000-09-21       Impact factor: 11.025

Review 2.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

3.  A novel Gli3 enhancer controls the Gli3 spatiotemporal expression pattern through a TALE homeodomain protein binding site.

Authors:  Sarah Coy; Jorge H Caamaño; Jaime Carvajal; Michael L Cleary; Anne-Gaëlle Borycki
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

4.  Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations.

Authors:  Jennifer J Johnston; Julie C Sapp; Joyce T Turner; David Amor; Salim Aftimos; Kyrieckos A Aleck; Maureen Bocian; Joann N Bodurtha; Gerald F Cox; Cynthia J Curry; Ruth Day; Dian Donnai; Michael Field; Ikuma Fujiwara; Michael Gabbett; Moran Gal; John M Graham; Peter Hedera; Raoul C M Hennekam; Joseph H Hersh; Robert J Hopkin; Hülya Kayserili; Alexa M J Kidd; Virginia Kimonis; Angela E Lin; Sally Ann Lynch; Melissa Maisenbacher; Sahar Mansour; Julie McGaughran; Lakshmi Mehta; Helen Murphy; Margarita Raygada; Nathaniel H Robin; Alan F Rope; Kenneth N Rosenbaum; G Bradley Schaefer; Amy Shealy; Wendy Smith; Maria Soller; Annmarie Sommer; Heather J Stalker; Bernhard Steiner; Mark J Stephan; David Tilstra; Susan Tomkins; Pamela Trapane; Anne Chun-Hui Tsai; Margot I Van Allen; Pradeep C Vasudevan; Bernhard Zabel; Janice Zunich; Graeme C M Black; Leslie G Biesecker
Journal:  Hum Mutat       Date:  2010-10       Impact factor: 4.878

5.  Role of FGFR2-signaling in the pathogenesis of acne.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2009-05

Review 6.  New paradigms for the Hedgehog signaling network in mammary gland development and breast Cancer.

Authors:  Teresa Monkkonen; Michael T Lewis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-06-15       Impact factor: 10.680

7.  Genetic Testing in a Cohort of Complex Esophageal Atresia.

Authors:  Eliane Beauregard-Lacroix; Jessica Tardif; Emmanuelle Lemyre; Zoha Kibar; Christophe Faure; Philippe M Campeau
Journal:  Mol Syndromol       Date:  2017-06-16

8.  Human intronic enhancers control distinct sub-domains of Gli3 expression during mouse CNS and limb development.

Authors:  Amir A Abbasi; Zissis Paparidis; Sajid Malik; Fiona Bangs; Ansgar Schmidt; Sabine Koch; Javier Lopez-Rios; Karl-Heinz Grzeschik
Journal:  BMC Dev Biol       Date:  2010-04-28       Impact factor: 1.978

9.  GLIS3, a novel member of the GLIS subfamily of Krüppel-like zinc finger proteins with repressor and activation functions.

Authors:  Yong-Sik Kim; Gen Nakanishi; Mark Lewandoski; Anton M Jetten
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

10.  Point mutations in GLI3 lead to misregulation of its subcellular localization.

Authors:  Sybille Krauss; Joyce So; Melanie Hambrock; Andrea Köhler; Melanie Kunath; Constance Scharff; Martina Wessling; Karl-Heinz Grzeschik; Rainer Schneider; Susann Schweiger
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.